Alamar Biosciences Inc.

04/22/2026 | Press release | Distributed by Public on 04/22/2026 14:17

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Qiming Corporate GP VI, Ltd.
2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ALMR]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O MAPLES CORPORATE SERVICES LIMITED, PO BOX 309
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026
(Street)
UGLAND HOUSE KY1-1104
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class B Common Stock 04/20/2026 C 185,163 A (1)(2) 185,163 I See footnote(3)
Class B Common Stock 04/20/2026 C 6,881,410 A (1)(2) 6,881,410 I See footnote(4)
Class B Common Stock 04/20/2026 C 1,605,645 A (1) 1,605,645 I See footnote(5)
Class B Common Stock 04/20/2026 C 1,922,329 A (1) 1,922,329 I See footnote(6)
Class B Common Stock 04/20/2026 J(7) 185,163 D (7) 0 I See footnote(3)
Class B Common Stock 04/20/2026 J(7) 6,881,410 D (7) 0 I See footnote(4)
Class B Common Stock 04/20/2026 J(7) 1,605,645 D (7) 0 I See footnote(5)
Class B Common Stock 04/20/2026 J(7) 1,922,329 D (7) 0 I See footnote(6)
Common Stock 04/20/2026 J(7) 185,163 A (7) 185,163 I See footnote(3)
Common Stock 04/20/2026 J(7) 6,881,410 A (7) 6,881,410 I See footnote(4)
Common Stock 04/20/2026 J(7) 1,605,645 A (7) 1,605,645 I See footnote(5)
Common Stock 04/20/2026 J(7) 1,922,329 A (7) 1,922,329 I See footnote(6)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A-3 Preferred Stock (1) 04/20/2026 C 172,328 (1) (1) Class B Common Stock 71,268 $ 0 0 I See footnote(3)
Series A-3 Preferred Stock (1) 04/20/2026 C 6,404,332 (1) (1) Class B Common Stock 2,648,607 $ 0 0 I See footnote(4)
Series A-4 Preferred Stock (1) 04/20/2026 C 154,425 (1) (1) Class B Common Stock 63,864 $ 0 0 I See footnote(3)
Series A-4 Preferred Stock (1) 04/20/2026 C 5,738,971 (1) (1) Class B Common Stock 2,373,437 $ 0 0 I See footnote(4)
Series B Preferred Stock (2) 04/20/2026 C 113,625 (2) (2) Class B Common Stock 50,031 $ 0 0 I See footnote(3)
Series B Preferred Stock (2) 04/20/2026 C 4,222,738 (2) (2) Class B Common Stock 1,859,366 $ 0 0 I See footnote(4)
Series C Preferred Stock (1) 04/20/2026 C 3,882,451 (1) (1) Class B Common Stock 1,605,645 $ 0 0 I See footnote(5)
Series C Preferred Stock (1) 04/20/2026 C 4,648,194 (1) (1) Class B Common Stock 1,922,329 $ 0 0 I See footnote(6)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Qiming Corporate GP VI, Ltd.
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming Managing Directors Fund VI, L.P.
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming Venture Partners VI, L.P.
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming GP VIII, LLC
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming Venture Partners VIII Investments, LLC
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming GP VIII-HC, LLC
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X
Qiming Venture Partners VIII-HC, L.P.
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
UGLAND HOUSE KY1-1104
X

Signatures

Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date
Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager 04/22/2026
**Signature of Reporting Person Date
Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date
Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date
Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date
Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date
Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory 04/22/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.
(2) Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date.
(3) These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
(4) These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
(5) These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
(6) These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
(7) Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Alamar Biosciences Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 22, 2026 at 20:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]